MVM Partners, LLC - 13 Aug 2026 Form 4 Insider Report for MDxHealth SA (MDXH)

Reporting relationship: Director
Issuer ticker: MDXH
Reported as of: 13 Aug 2026
Net transaction value: +$1,000,000
SEC form: 4
Accepted by SEC: 17 Aug 2026, 16:05:06 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Busch, as attorney-in-fact for MVM Partners, LLC

Key filing fact

MVM Partners, LLC filed Form 4 for MDxHealth SA (MDXH) on 17 Aug 2026.

Key facts

This page summarizes MVM Partners, LLC's Form 4 filing for MDxHealth SA (MDXH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2026, 16:05.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: +$1,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001947083 Primary reporting owner

MVM Partners, LLC

Relationship: Director
Address: OLD CITY HALL, 45 SCHOOL STREET, BOSTON
Signature: /s/ Mark Busch, as attorney-in-fact for MVM Partners, LLC
Signature date: 17 Aug 2026

CIK 0001897581

Bednarski Eric

Relationship: Director
Address: CAP BUSINESS CENTER, ZONE INDUSTRIELLE DES HAUTS-SARTS, HERSTAL, BELGIUM
Signature: /s/ Mark Busch, as attorney-in-fact for MVM Partners, LLC
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDXH transaction

Ordinary Shares

Purchase

Transaction value: $1,000,000
Shares: +2,202,643
Change %: +47%
Price: $0.4540
Shares after: 6,903,100
Date: 13 Aug 2026
Ownership: See Footnote
Footnotes: F1, F2

MDXH transaction

Ordinary Shares

Purchase

Transaction value: $1,000,000
Shares: +2,202,643
Change %: +47%
Price: $0.4540
Shares after: 6,903,100
Date: 13 Aug 2026
Ownership: See Footnote
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Ordinary shares, no par value, of MDxHealth SA (the "Issuer") purchased pursuant to securities purchase agreements by and between the Issuer and certain private investment vehicles managed by MVM Partners, LLC (the "Funds"), each dated as of August 11, 2026.

Footnote F2

The securities reported herein are directly owned by the Funds. The securities may also be deemed beneficially owned by MVM Partners, LLC ("MVM") as the investment manager of the Funds and by Eric Bednarski as Managing Member of MVM. Each of Mr. Bednarski and MVM disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interests therein, if any, and this Form 4 shall not be deemed an admission that either Mr. Bednarski or MVM is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.